CJ Bioscience, Inc. (KOSDAQ:311690)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,010
-90 (-0.89%)
At close: Apr 2, 2025, 3:30 PM KST

CJ Bioscience Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
8,30964,09549,32462,06013,255
Upgrade
Short-Term Investments
67,000--18,020-
Upgrade
Trading Asset Securities
----26,020
Upgrade
Cash & Short-Term Investments
75,30964,09549,32480,08039,275
Upgrade
Cash Growth
17.50%29.95%-38.41%103.89%26.35%
Upgrade
Accounts Receivable
72.57160.91303.82233.6299.46
Upgrade
Other Receivables
623.2178.66523.06474.16257.47
Upgrade
Receivables
695.77339.57826.88707.78356.93
Upgrade
Inventory
128.75157.8276.16145.83364.31
Upgrade
Prepaid Expenses
294.56355.71446.57259.18499.9
Upgrade
Other Current Assets
333.6262.22258.72362.03592.63
Upgrade
Total Current Assets
76,76265,21050,93281,55541,089
Upgrade
Property, Plant & Equipment
8,90712,70714,3649,85619,991
Upgrade
Long-Term Investments
2220-
Upgrade
Other Intangible Assets
12,49912,3971,016114.13103.95
Upgrade
Other Long-Term Assets
1,439811.1625,07524,83012,178
Upgrade
Total Assets
99,61091,12891,389116,35573,362
Upgrade
Accounts Payable
220.83122.82336.65287.75708.93
Upgrade
Accrued Expenses
3,2343,9663,996140.94169.76
Upgrade
Short-Term Debt
6,3653,97123,58818,441-
Upgrade
Current Portion of Leases
1,8241,8691,5471,361205.9
Upgrade
Other Current Liabilities
6,8824,7935,5113,6061,919
Upgrade
Total Current Liabilities
18,52514,72234,97923,8363,004
Upgrade
Long-Term Debt
----35,081
Upgrade
Long-Term Leases
1,1622,6923,8314,088479.37
Upgrade
Other Long-Term Liabilities
2,1662,1522,924577.4314.4
Upgrade
Total Liabilities
21,85319,63341,73428,50238,878
Upgrade
Common Stock
6,5334,5562,9392,9371,946
Upgrade
Additional Paid-In Capital
189,419151,426108,066112,18640,993
Upgrade
Retained Earnings
-119,067-85,951-62,738-28,035-8,763
Upgrade
Comprehensive Income & Other
872.041,4651,389765.25307.61
Upgrade
Shareholders' Equity
77,75771,49649,65587,85334,484
Upgrade
Total Liabilities & Equity
99,61091,12891,389116,35573,362
Upgrade
Total Debt
9,3518,53328,96623,89135,766
Upgrade
Net Cash (Debt)
65,95855,56220,35756,1903,509
Upgrade
Net Cash Growth
18.71%172.93%-63.77%1501.15%-88.44%
Upgrade
Net Cash Per Share
7112.487844.653463.5013214.21908.96
Upgrade
Filing Date Shares Outstanding
9.769.115.885.873.89
Upgrade
Total Common Shares Outstanding
9.769.115.885.873.89
Upgrade
Working Capital
58,23650,48815,95357,71838,085
Upgrade
Book Value Per Share
7969.487845.898446.7114957.108859.45
Upgrade
Tangible Book Value
65,25759,09848,64087,73934,380
Upgrade
Tangible Book Value Per Share
6688.396485.408273.8914937.678832.74
Upgrade
Land
----13,973
Upgrade
Buildings
----2,563
Upgrade
Machinery
14,05113,68610,3394,4113,488
Upgrade
Construction In Progress
--521.7--
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.